Clinical Trials Directory

Trials / Conditions / Systemic Lupus Erthematosus

Systemic Lupus Erthematosus

17 registered clinical trials studyying Systemic Lupus Erthematosus — 13 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of GR1803 in Systemic Lupus Erythematosus
NCT07348055
Genrix (Shanghai) Biopharmaceutical Co., Ltd.Phase 1 / Phase 2
Not Yet RecruitingMass Spectrometry-based Immune Profiling in Autoimmune Diseases
NCT07188285
Peking University People's Hospital—
CompletedWater-based Liuzijue Exercise on Childhood-onset Systemic Lupus Erythematosus
NCT07024082
MTI UniversityN/A
RecruitingSafety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
NCT06828042
Peking University Third HospitalPhase 1 / Phase 2
Not Yet RecruitingFibroblast Growth Factor 21 in Systemic Lupus Erythematosus
NCT06842810
Assiut University—
RecruitingCardiovascular Risk in Children With Chronic Conditions Study
NCT07086989
Semmelweis University—
RecruitingSafety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematos
NCT07136389
BiocadPhase 1
Not Yet RecruitingSafety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of R
NCT06821659
Peking University Third HospitalPhase 1 / Phase 2
RecruitingAnti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
NCT06792799
The Children's Hospital of Zhejiang University School of MedicineEARLY_Phase 1
RecruitingUC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
NCT06737380
LiveKidney.BioPhase 1
RecruitingCOVID-19 Booster and IIV Schedule in Immunocompromised Hosts
NCT06599658
McGill University Health Centre/Research Institute of the McGill University Health CentrePhase 2
CompletedFatigue in Systemic Lupus Erythematosus
NCT06652256
Pamukkale University—
RecruitingRare AutoImmune SElf-management Programme Development
NCT06642870
University of the West of England—
Not Yet RecruitingBone Mineral Density in Patients With Childhood-onset Systemic Lupus Erythematous, in Relation to Disease Clin
NCT06586359
Assiut University—
CompletedRenal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity
NCT06757725
Kasr El Aini HospitalN/A
RecruitingPatient-Centered Assessment of Symptoms and Outcomes
NCT03952624
National Center for Complementary and Integrative Health (NCCIH)—
CompletedOmalizumab for Lupus
NCT01716312
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Phase 1